Radioactive 'Tumor-Seeking' drug tested to boost cancer surgery success
NCT ID NCT04609592
Summary
This small, early-stage study is testing whether it is safe and practical to give a targeted radioactive treatment (called PRRT) both before and after surgery to remove certain slow-growing digestive tract tumors that have spread. The goal is to see if this combined approach helps control the cancer better and keeps patients living longer. The study will enroll about 10 people with specific types of metastatic neuroendocrine tumors who are already candidates for surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROENTEROPANCREATIC NEUROENDOCRINE TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Stanford Cancer Institute Palo Alto
RECRUITINGStanford, California, 95304, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.